Catalyst Pharmaceuticals Inc (CPRX)

Operating profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	86,812	101,838	52,385	41,303	31,823
Revenue	US$ in thousands	398,204	214,203	140,833	119,073	102,306
Operating profit margin		21.80%	47.54%	37.20%	34.69%	31.11%

December 31, 2023 calculation

Operating profit margin = Operating income ÷ Revenue
= $86,812K ÷ $398,204K
= 21.80%

The operating profit margin of Catalyst Pharmaceuticals Inc has experienced fluctuations over the past five years. In 2019, the operating profit margin stood at 31.11%, increasing to 34.69% in 2020, and further to 37.20% in 2021. However, there was a significant decline in 2022, with the operating profit margin dropping to 47.54%. The most recent data for 2023 shows a further decrease in the operating profit margin to 21.80%.

These fluctuations in the operating profit margin may indicate varying levels of efficiency and profitability in the company's operations over the years. The significant decrease in 2022 followed by a further decline in 2023 suggests potential challenges or changes in the company's cost structure, revenue generation, or overall business performance. Further analysis would be needed to identify the specific factors contributing to these fluctuations and to assess the company's overall financial health and operational effectiveness.